Framework of the strategy In the comIng perIod. The comIng perIod. Also, we have talked the comIng perIod. Also, we have talked about the comIng perIod. Also, we have talked about the the comIng perIod. Also, we have talked about the gIantl have talked about the gIant commItment, and also. And also, presIdent Joe BIden to develop and further develop the economIc and cultural relatIons and socIal ones as well. And we have talked as well about dIfferent other bIlateral fIles. We have talked about the egyptIan and afrIcan and arab candIdates for the unesco posItIon, and the Importance of lIftIng the InjustIce targeted at the arabIc and egyptIan cIvIlIsatIon, to have the DIrector General Of Unesco from egypt and from the arab countrIes, and we have talked about some other regIonal fIles and InternatIonalfIles, the and InternatIonal fIles, the dangerous and InternatIonalfIles, the dangerous challenges that threaten the Safety And StabIlIty of the MIddle East and the afrIcan content and the
And another vaccine, developed by us manufacturerjohnson johnson, is the latest to prove effective in phase three trials. In other news primary schools in wales could re open to all pupils after half term, though the nationwide lockdown will continue. Thousands of volunteers helping the nhs with the Vaccine Roll Out will be prioritised for a jab. Hello to you, welcome to bbc news. The European Union has introduced Export Controls on Coronavirus Vaccines. Individual Member States will decide whether to allow exports of vaccines produced in their territory. A European Commissioner said it was being introduced to enhance transparency and to ensure that all eu citizens had access to vaccines. A European Commissioner, valdis dombrovskis, made the Announcement A little earlier this afternoon. The protection and safety of our citizens is a priority. And the challenges we now face left us with no other choice but to act. Vaccines are key to the recovery, and to bringing the pandemic under cont
Good evening. My name is trevor fromhe boston book festival. Thank you so much for joining us this afternoons 2020 session, can business save the world. I would especiall like to think everyone including a donation en they register for this free event. It would like to purchase the book by todays presenters, were also suppoing independent bookstores in the bbf, which made it easy. Just cli by t book linkt the bottom of the screen. No i like to talk about them moderator, cofounder of fsg and the author of influential publicions on sharealue catalytic herapy, strategic evuations and impact insting. Thank you trevor and it is wonderful to be here and these ar two outstanding womanhood just written two books the long and a book shelf. Where used to thinking about business as being the source of so any problems in the world today. Its quite refreshing to he a panel that talks abo whether business can save the world and while that is a large and openended question. Trevor our two authors tod
Oall the urgency to have a safe and effective vaccine available and with those being developed with socalled warp speed interest and understanding the E Development process has never been greater. Weve got the experts both inside and out to help us do that. Let me briefly introduce our speakers today. The 24th commissioner of the food and Drug Administration and clinician having trained in both medical oncology and radiation oncology. Prior to joining he served as the chief medical executive is the university of texas and the anderson cancer center. Before that he chaired the department oncology at the university of Pennsylvania School of medicine. Twentyfirst commissioner of the fda before that founding Vice President and Senior Scientist at the Nuclear Threats initiative, a foundation dedicated to reducing Nuclear Chemical and biological threats. More recently the foreign secretary for the president and board chair of the association for the advancement of science. For the oped at th
Covid19 vaccine available and with those vaccines developed at socalled warp speed interest in understanding the process has never been greater. The fda inside and out, they have to do that. Let me briefly introduce our incredible speakers today. Dr. Stephen hahn is the 20 fourth administer of the fda, having trained in medical oncology and radiation oncology, prior to joining the fda served as chief medical executive at the university of texas cancer center. Before that he chaired the permit of radiation oncology at the university, and the alma mater. And the commission of the fda, before that was founding Vice President and Senior Scientist at the Nuclear Threat initiative, foundation dedicated to biological threats. Recently dr. Margaret hamburg was foreign secretary, at the American Association for advancement of science. She completed her services at the organization. Commissioners dr. Margaret hamburg and dr. Stephen hahn will be talking to clifton leaf who was guest editor of th